Literature DB >> 25433730

Papillary thyroid microcarcinomas located at the middle part of the middle third of the thyroid gland correlates with the presence of neck metastasis.

Dapeng Xiang1, Liangqi Xie2, Yuanliang Xu1, Zhiyu Li3, Yurong Hong4, Ping Wang1.   

Abstract

BACKGROUND: Papillary thyroid microcarcinomas (PTMCs), located at upper poles of the thyroid, are associated with lateral neck metastasis (LNM) according to previous reports. Controversy remains regarding the correlation between the location of PTMCs and central neck metastasis (CNM).
METHODS: Medical records of 949 patients with PTMCs diagnosed between 2010 and 2013 were reviewed retrospectively. With a subdivision of the middle third of the thyroid gland, correlations between tumor location and CNM/LNM along with other clinicopathologic factors were analyzed by binary logistic regression.
RESULTS: PTMCs located in the middle part of the middle third of the thyroid gland (MPMT) showed the greatest rate of CNM (57.5%) among all locations. PTMCs located at isthmus showed the second greatest rate of CNM (44.3%). In the multivariate analysis, MPMT, tumor size >0.5 cm, young and middle age, male sex, multifocality within the affected lobe, and capsular invasion were correlated with CNM. PTMCs located at upper poles and MPMT showed comparatively high rates of LNM (8.6% and 8.3%). Consistent with previous reports, an upper pole location, MPMT, and a tumor size >0.5 cm greatly correlated with LNM in the multivariate analysis. Eleven patients had skip metastases, which only occurred with upper/lower pole locations and MPMT.
CONCLUSION: PTMCs located in the MPMT correlated with both CNM and LNM. Tumor location along with other clinicopathologic factors such as young and middle age, male sex, and tumor size >0.5 cm could facilitate preoperative stratification and guide operative management for patients with PTMC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25433730     DOI: 10.1016/j.surg.2014.10.020

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

Review 1.  The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Liang-Sen Liu; Jia Liang; Jun-Hong Li; Xue Liu; Li Jiang; Jian-Xiong Long; Yue-Ming Jiang; Zhi-Xiao Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-19       Impact factor: 2.503

2.  Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.

Authors:  Hong Gao; Xiaosong Sun; Hongdong Wang; Ying Zheng
Journal:  Cell Cycle       Date:  2020-04-19       Impact factor: 4.534

3.  Endoscopic thyroidectomy along with bilateral central neck dissection (ETBC) increases the risk of transient hypoparathyroidism for patients with thyroid carcinoma.

Authors:  Dapeng Xiang; Liangqi Xie; Zhiyu Li; Ping Wang; Mao Ye; Mingzhu Zhu
Journal:  Endocrine       Date:  2016-02-17       Impact factor: 3.633

4.  2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS.

Authors:  JianQiao Zhou; LiXue Yin; Xi Wei; Sheng Zhang; YanYan Song; BaoMing Luo; JianChu Li; LinXue Qian; LiGang Cui; Wen Chen; ChaoYang Wen; YuLan Peng; Qin Chen; Man Lu; Min Chen; Rong Wu; Wei Zhou; EnSheng Xue; YingJia Li; LiChun Yang; ChengRong Mi; RuiFang Zhang; Gang Wu; GuoQing Du; DaoZhong Huang; WeiWei Zhan
Journal:  Endocrine       Date:  2020-08-21       Impact factor: 3.633

5.  Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.

Authors:  Xilin Nie; Zhou Tan; Minghua Ge
Journal:  BMC Cancer       Date:  2017-10-25       Impact factor: 4.430

6.  CUNR scoring system for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma.

Authors:  Jianyong Lei; Gengpeng Li; Zhihui Li; R X Rong; Jingqiang Zhu
Journal:  Oncotarget       Date:  2017-11-30

7.  Lymph node metastasis characteristics of papillary thyroid carcinoma located in the isthmus: A single-center analysis.

Authors:  Genpeng Li; Jianyong Lei; Qian Peng; Ke Jiang; Wenjie Chen; Wanjun Zhao; Zhihui Li; Rixiang Gong; Tao Wei; Jingqiang Zhu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

8.  MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4.

Authors:  Zhenzhong Fa; Zhenyu Min; Jianjun Tang; Chuanlei Liu; Guodu Yan; Jianbo Xi
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

9.  Establishment and validation of the scoring system for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma.

Authors:  Wen Liu; Ruochuan Cheng; Yunhai Ma; Dan Wang; Yanjun Su; Chang Diao; Jianming Zhang; Jun Qian; Jin Liu
Journal:  Sci Rep       Date:  2018-05-03       Impact factor: 4.379

10.  Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.

Authors:  Yanjie Shuai; Kai Yue; Yuansheng Duan; Mengqian Zhou; Yan Fang; Jin Liu; Dandan Liu; Chao Jing; Yansheng Wu; Xudong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-15       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.